All News

September 17, 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000 square-foot R&D cell therapy manufacturing facility at its R&D headquarters in Boston, Massachusetts. The facility provides end-to-end research and development capabilities and will accelerate Takeda’s efforts to develop next-generation cell therapies, initially focused on oncology with potential to expand into other therapeutic areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200915005224/en/ “We are collaborating with some of the best scientists and innovators around the world establishing a highly differentiated immuno-oncology pipeline leapfrogging into new modalities and mechanisms with curative potential,” said Chris Arendt, Ph.D., Head of Takeda’s Oncology Therapeutic Area Unit. “With three oncology cell therapy programs in the clinic and two more targeted to enter the clinic in fiscal year 2021, we are working with urgency and purpose for patients. This new facility helps us rapidly scale our manufacturing capabilities so we can simultaneously advance multiple highly differentiated cell therapy programs.” Oncology cell therapy is a type of immunotherapy that uses genetically modified immune cells to find and kill......

Continue Reading >

September 17, 2020

Neustar, Inc., a global information services and technology company and leader in identity resolution, today released its latest cyberthreats and trends report which identifies significant shifts in distributed denial-of-service (DDoS) attack patterns in the first half of 2020. Neustar’s Security Operations Centre (SOC) saw a 151% increase in the number of DDoS attacks compared to the same period in 2019. These included the largest and longest attacks that Neustar"...

Continue Reading >

September 17, 2020

The coronavirus has brought grave challenges to the economic conditions, education, health, employment and rights protection of women who must themselves be lifted out of poverty if mankind is to eliminate poverty overall, Chinese First Lady Peng Liyuan told a videoconference on Wednesday.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200917005380/en/

Peng, speaking on the 25th anniversary of the Beijing World Women's"...

Continue Reading >

September 17, 2020

As remote production for sports ramps up around the globe, SES is providing broadcasters with a newly opened, full-service sports and events facility in Greater London. Apart from handling downlink, decoding, processing and recording, SES’s Stockley Park facility offers sports broadcasters a range of services that help simplify sports production workflow.

The video services offered at SES’s Stockley Park facility range from content management services such as clipping and editing, subtitling, audio dubbing and titling, storing and archiving of content for easy retrieval to channel playout services to multiple broadcast or online platforms."...

Continue Reading >

September 17, 2020

ExaGrid®, the industry’s only Tiered Backup Storage solution, today announced the release of software Version 6.0, which begins shipping on September 18, 2020.

Key features include:

New Retention Time-Lock for Ransomware Recovery

Retention Time-Lock is a revolutionary approach to protecting backup retention data to enable fast and easy recovery from ransomware.

September 17, 2020

During Apsara Conference 2020, the digital technology and intelligence backbone of Alibaba Group, unveiled a series of artificial intelligence (AI) powered solutions which are set to transform and digitalize the way sports entertainment was traditionally organized, broadcast and consumed. The solutions are designed to bring spectators closer to the events’ center stage for more personalized and interactive engagement, while helping organizers and broadcasters operate more efficiently, effectively and securely.

Event organizers are set to benefit considerably from Alibaba Cloud’s ...

Continue Reading >

September 17, 2020

Alibaba Cloud, the digital technologies and intelligence backbone of Alibaba Group, today unveiled a series of innovative products at its 12th annual Apsara Conference, highlighting the technology pioneer’s commitment in helping people adapt to the more digitized world and accelerate customers’ digital transformation during and after the pandemic.

A highlight is Alibaba Cloud’s first cloud computer, a palm-sized personal computer which, despite being just about 60 grams and as light as an egg, offers high-performance computing, thanks to robust back-end cloud resources. By simply connecting the cloud computer with a normal computer"...

Continue Reading >

September 17, 2020

Preqin is pleased to announce that it has established a new permanent office in Dubai, United Arab Emirates. This location marks Preqin’s 12th office opening, and its second in EMEA. Having opened three other new office locations in the past 12 months, the company now employs more than 600 people in nine countries on four continents.

Located in the Dubai International Finance Center (DIFC), the office opens with a team of three staff dedicated to serving the alternative assets community in the Middle East. Over the next six months, Preqin expects to grow that to five people.

Ben"...

Continue Reading >

September 17, 2020

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization (CRO) announces the acquisition of Clinart, a full-service CRO with nearly 20 years of experience and strong local expertise in the Middle East and Northern Africa (MENA) region.

Clinart provides an extensive array of services, from early to late-stage research as well as product support in accordance with global and regional requirements. Additionally, the Clinart footprint augments CTI’s current reach in the MENA region, with associates in Egypt, Morocco, Tunisia, Lebanon, Saudi Arabia, Kuwait, Jordan, Oman, and United"...

Continue Reading >

September 17, 2020

  • First clinical study to evaluate novel combination blocking KRAS G12C and its activator SOS1 to potentially increase the therapeutic benefit for lung and colorectal cancer patients
  • Study is based on preclinical evidence suggesting synergistic effect of KRAS G12C and SOS1 inhibition

Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation type, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors that harbor the KRAS G12C mutation. The collaboration will investigate the potential of this combination to provide more"...

Continue Reading >